Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
1.900
-0.080 (-4.04%)
At close: Dec 20, 2024, 9:51 AM
1.950
+0.050 (2.63%)
After-hours: Dec 20, 2024, 4:00 PM EST
Armata Pharmaceuticals Employees
Armata Pharmaceuticals had 66 employees as of December 31, 2023. The number of employees decreased by 9 or -12.00% compared to the previous year.
Employees
66
Change (1Y)
-9
Growth (1Y)
-12.00%
Revenue / Employee
$82,833
Profits / Employee
-$626,712
Market Cap
70.56M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Burning Rock Biotech | 786 |
P3 Health Partners | 400 |
Vigil Neuroscience | 69 |
ESSA Pharma | 50 |
Vivani Medical | 44 |
Oncolytics Biotech | 29 |
Milestone Scientific | 17 |
Unicycive Therapeutics | 14 |
ARMP News
- 2 days ago - Armata Pharmaceuticals Announces Encouraging Results from the Phase 2 Tailwind Study of Inhaled AP-PA02 in Non-Cystic Fibrosis Bronchiectasis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection - PRNewsWire
- 4 weeks ago - Armata Pharmaceuticals Announces that CEO Dr. Deborah Birx Will Deliver a Presentation at the 5th Annual Phage Futures Annual Meeting - PRNewsWire
- 5 weeks ago - Armata Pharmaceuticals Announces Third Quarter 2024 Results and Provides Corporate Update - PRNewsWire
- 5 weeks ago - Armata Pharmaceuticals Announces the Completion of Enrollment of its Phase 1b/2a diSArm Study Evaluating Intravenous AP-SA02 as a Potential Treatment for Staphylococcus aureus Bacteremia - PRNewsWire
- 7 weeks ago - Armata Pharmaceuticals Announces Structural Biology Publication - PRNewsWire
- 3 months ago - Armata Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - PRNewsWire
- 4 months ago - Armata Pharmaceuticals Announces Presentation at the 2024 Military Health System Research Symposium - PRNewsWire
- 4 months ago - Armata Pharmaceuticals Announces Appointment of Life Sciences Accounting and Finance Veteran David House as SVP of Finance and Principal Financial Officer - PRNewsWire